Postmarket Requirements and Commitments

Postmarket requirement and commitment studies and clinical trials occur after a drug or biological product has been approved by FDA.  For more information, please read: "Report to Congress: Reports on Postmarketing Studies [FDAMA 130]" and the Guidance for Industry (PDF - 456KB). A separate Web site is available for post approval studies for medical devices.




Downloadable Database File

FDA Home | Drugs Home | Vaccines, Blood & Biologics Home
PMC Coordinator:

FDA/Center for Drug Evaluation and Research
Office of New Drugs
Update Frequency: Quarterly
Database Last Updated: October 27, 2021

Page Last Updated: 08/09/2013
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English